J. S. Lee

625 total citations
17 papers, 392 citations indexed

About

J. S. Lee is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, J. S. Lee has authored 17 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in J. S. Lee's work include Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). J. S. Lee is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). J. S. Lee collaborates with scholars based in South Korea. J. S. Lee's co-authors include Yoon‐Koo Kang, Jeong Hwan Yook, Heung Moon Chang, Jung‐Hyuck Ahn, Sooyeon Oh, Hong‐Seok Park, Seung‐Baik Kang, Jun-Gu Park, T. W. Kim and M.-H. Ryu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

J. S. Lee

17 papers receiving 380 citations

Peers

J. S. Lee

PRM

ONCOL

SURGE

Agustín Seoane Spain

Rashpal Flora United Kingdom

Thomas Zaramboukas Greece

Nikos Courcoutsakis Greece

Kou Kaneko Japan

Kota Washimi Japan

Rudolf Bongartz Germany

Daniela Katz Israel

Junichi Shiraishi Japan

Berrin Ustun United States

Agustín Seoane Spain

J. S. Lee

204 ×0.9

PRM

257 ×1.4

ONCOL

189 ×1.2

SURGE

33 ×0.5

45 ×0.9

Citations per year, relative to J. S. Lee J. S. Lee (= 1×) peers Agustín Seoane

Countries citing papers authored by J. S. Lee

Since Specialization

Citations

This map shows the geographic impact of J. S. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. S. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. S. Lee more than expected).

Fields of papers citing papers by J. S. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. S. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. S. Lee. The network helps show where J. S. Lee may publish in the future.

Co-authorship network of co-authors of J. S. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of J. S. Lee. A scholar is included among the top collaborators of J. S. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. S. Lee. J. S. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kim, S, J. S. Lee, Keon Bong Oh, & Jeong Ho Hwang. (2023). Vitamin C promotes the early reprogramming of fetal canine fibroblasts into induced pluripotent stem cells. SHILAP Revista de lepidopterología. 38(4). 199–208. 1 indexed citations

Lee, Je‐Hwan, et al.. (2019). Association of plasma fibrinogen concentrations and blood eosinophil counts with clinical phenotypes of COPD. The International Journal of Tuberculosis and Lung Disease. 23(9). 1035–1041. 3 indexed citations

Kim, Wook‐Jong, J. S. Lee, & Hye Won Chung. (2018). Outcomes after extensive manual curettage and limited burring for atypical cartilaginous tumour of long bone. The Bone & Joint Journal. 100-B(2). 256–261. 4 indexed citations

Kang, Seung‐Baik, et al.. (2017). Staged lengthening and reconstruction for children with a leg-length discrepancy after excision of an osteosarcoma around the knee. The Bone & Joint Journal. 99-B(3). 401–408. 22 indexed citations

Park, Seong Ho, J. S. Lee, Hwan Heo, et al.. (2014). A Nationwide Population-Based Study of Low Vision and Blindness in South Korea. Investigative Ophthalmology & Visual Science. 56(1). 484–493. 22 indexed citations

Kim, Jong Soo, Joo‐Shik Shin, Kwang Pyo Kim, et al.. (2013). INCB018424 induces apoptotic cell death through the suppression of pJAK1 in human colon cancer cells. Neoplasma. 61(1). 56–62. 10 indexed citations

Yoon, Dok Hyun, Dae Ro Choi, Byeong Seok Sohn, et al.. (2010). Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience. Bone Marrow Transplantation. 46(1). 105–109. 36 indexed citations

Lee, J. S., et al.. (2009). Metabolic syndrome and cancer-related mortality among Korean men and women. Annals of Oncology. 21(3). 640–645. 41 indexed citations

Ahn, Hee‐Sung, Jung‐Min Koh, Inkeun Park, et al.. (2009). Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma. Japanese Journal of Clinical Oncology. 39(5). 327–331. 29 indexed citations

10.

Jo, Jae‐Cheol, J.-L. Lee, M.-H. Ryu, et al.. (2007). Docetaxel Monotherapy as a Second-line Treatment after Failure of Fluoropyrimidine and Platinum in Advanced Gastric Cancer: Experience of 154 Patients with Prognostic Factor Analysis. Japanese Journal of Clinical Oncology. 37(12). 936–941. 32 indexed citations

11.

Lee, J.-L., et al.. (2005). Efficacy and safety study of docetaxel as salvage chemotherapy in metastatic gastric cancer failing fluoropyrimidine and platinum combination chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 4220–4220. 5 indexed citations

12.

Chang, Heung-Moon, et al.. (2005). Phase II trial of gemcitabine plus capecitabine in patients with advanced biliary tract cancer. Journal of Clinical Oncology. 23(16_suppl). 4173–4173. 2 indexed citations

13.

Kim, T. W., Heung-Moon Chang, Min‐Hee Ryu, et al.. (2004). A phase II study of paclitaxel and capecitabine combination chemotherapy in patients with advanced gastric cancer as a first-line therapy. Journal of Clinical Oncology. 22(14_suppl). 4051–4051. 8 indexed citations

14.

Kim, T. W., et al.. (2004). A phase II study of paclitaxel and capecitabine combination chemotherapy in patients with advanced gastric cancer as a first-line therapy. Journal of Clinical Oncology. 22(14_suppl). 4051–4051. 4 indexed citations

15.

Chang, Heung-Moon, et al.. (2004). Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer. Journal of Clinical Oncology. 22(14_suppl). 4219–4219. 2 indexed citations

16.

Kim, J., Hongsik Moon, Thad T. Ghim, et al.. (2003). Idiopathic Thrombocytopenic Purpura: Better Therapeutic Responses of Patients with B- or T-Cell Clonality than Patients without Clonality. International Journal of Hematology. 78(5). 461–466. 5 indexed citations

17.

Kang, Yoon‐Koo, Jung‐Hyuck Ahn, Heung Moon Chang, et al.. (2002). Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer. Annals of Oncology. 13(12). 1893–1898. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact